| Announce Date | 02/11/2026 |
| EPS Normalized Actual | $1.8 (Beat by $0.02) |
| EPS GAAP Actual | $1.8 (Beat by $0.02) |
| Revenue Actual | $1.63024B |
| Revenue Surprise | Beat by $1630.24M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.36 |
| EPS GAAP Estimate | $1.36 |
| Revenue Estimate | $1.366B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 10.14 | 12.93 | 9.89199 | 10.47311 | 1 |
| Dec 2029 | 9.34 | 14.03 | 8.99586 | 10.02875 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.3374 | 0.65682 | 1.63024B | 12.49% | 491.53M |
| FQ2 2025 (Jun 2025) | 0.99 | 0.38462 | 1.44488B | 13.58% | 366.4M |
| FQ1 2025 (Mar 2025) | 0.84 | -0.28968 | 1.22264B | 12.79% | 67.1M |
| FQ4 2024 (Dec 2024) | 0.92 | -0.11714 | 1.78719B | 22.92% | 634.78M |
| FQ3 2024 (Sep 2024) | 0.94 | 0.35714 | 1.42657B | 24.95% | 343.77M |
| FQ2 2024 (Jun 2024) | 0.49 | -0.85259 | 1.24866B | 100% | -651.96M |
| FQ1 2024 (Mar 2024) | 0.79 | 0.79 | 1.06623B | 100% | 1066.23M |
| FQ3 2022 (Sep 2022) | 0.58 | 0.58 | 0.946897B | 100% | 946.9M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.36
Consensus Revenue Estimates
1.366B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 1.98273 | -- | 1.92408 | 2.17058 | 2 |
| FQ3 2026 (Sep 2026) | 1.61 | 16.93 | 1.54812 | 1.71002 | 2 |
| FQ2 2026 (Jun 2026) | 1.06 | 6.6 | 1.06 | 1.06 | 4 |
| FQ1 2026 (Mar 2026) | 1.36 | 38.24 | 1.36 | 1.36 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 2.22B | -- | 2.17B | 2.38B | 3 |
| FQ3 2026 (Sep 2026) | 1.83B | 10.77 | 1.77B | 1.91B | 4 |
| FQ2 2026 (Jun 2026) | 1.61B | 10.09 | 1.61B | 1.61B | 4 |
| FQ1 2026 (Mar 2026) | 1.37B | 10.49 | 1.37B | 1.37B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.68058 | 1.3374 | 0.65682 | 49.11% |
| FQ2 2025 (Jun 2025) | 0.60538 | 0.99 | 0.38462 | 38.85% |
| FQ1 2025 (Mar 2025) | 1.12968 | 0.84 | -0.28968 | -34.49% |
| FQ4 2024 (Dec 2024) | 1.03714 | 0.92 | -0.11714 | -12.73% |
| FQ3 2024 (Sep 2024) | 0.58286 | 0.94 | 0.35714 | 37.99% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.49 | -0.85259 | -174% |
| FQ1 2024 (Mar 2024) | 0.79 | 0.79 | 100% | |
| FQ3 2022 (Sep 2022) | 0.58 | 0.58 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.14B | $1.63B | $491.53M | 30.15% |
| FQ2 2025 (Jun 2025) | $1.08B | $1.44B | $366.4M | 25.36% |
| FQ1 2025 (Mar 2025) | $1.16B | $1.22B | $67.1M | 5.49% |
| FQ4 2024 (Dec 2024) | $1.15B | $1.79B | $634.78M | 35.52% |
| FQ3 2024 (Sep 2024) | $1.08B | $1.43B | $343.77M | 24.1% |
| FQ2 2024 (Jun 2024) | $1.9B | $1.25B | $-651.96M | -52.21% |
| FQ1 2024 (Mar 2024) | $0B | $1.07B | $1066.23M | 100% |
| FQ3 2022 (Sep 2022) | $0B | $0.95B | $946.9M | 100% |